Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China
· Delayed Price · Currency is CNY 60.70
+0.08 (0.13%)
Apr 29, 2026, 3:00 PM CST
SHA:688399 Revenue
In the year 2025, Jiangsu Bioperfectus Technologies had annual revenue of 339.05M CNY, down -3.02%. Jiangsu Bioperfectus Technologies had revenue of 81.54M in the quarter ending December 31, 2025, with 0.02% growth.
Revenue
339.05M
Revenue Growth
-3.02%
P/S Ratio
15.02
Revenue / Employee
572.72K
Employees
586
Market Cap
5.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 339.05M | -10.56M | -3.02% |
| Dec 31, 2024 | 349.61M | -53.57M | -13.29% |
| Dec 31, 2023 | 403.18M | -5.13B | -92.72% |
| Dec 31, 2022 | 5.53B | 2.70B | 94.95% |
| Dec 31, 2021 | 2.84B | 1.10B | 63.19% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ChemPartner PharmaTech | 1.07B |
| Hangzhou Biotest Biotech | 449.50M |
| Wuhan Hvsen Biotechnology | 1.68B |
| Assure Tech (Hangzhou) | 453.58M |
| Beijing Scitop Bio-tech | 373.31M |
| Beijing Konruns Pharmaceutical | 917.99M |
| Hinova Pharmaceuticals | 46.50M |
| Kexing Biopharm | 1.53B |